Ibrutinib inhibits pre-BCR(+) B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK

Targeting B-cell receptor (BCR) signaling is a successful therapeutic strategy in mature B-cell malignancies. Precursor BCR (pre-BCR) signaling, which is critical during normal B lymphopoiesis, also plays an important role in pre-BCR(+) B cell acute lymphoblastic leukemia (B-ALL). Here, we investiga...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Kim, Ekaterina, Hurtz, Christian, Koehrer, Stefan, Wang, Zhiqiang, Balasubramanian, Sriram, Chang, Betty Y., Müschen, Markus, Davis, R. Eric, Burger, Jan A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2017
Предметы:
Lymphoid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374732/
https://ncbi.nlm.nih.gov/pubmed/28031181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-06-722900
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы